Lisinopril for kidney protection
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril and Kidney Protection: Mechanisms and Evidence
Lisinopril for Reducing Kidney Injury and Proteinuria
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, has shown significant kidney-protective effects in various models of kidney injury. In studies involving acute kidney injury induced by toxins such as doxorubicin and sodium fluoride, lisinopril reduced markers of kidney damage, including serum creatinine, blood urea nitrogen (BUN), and oxidative stress indicators. It also improved antioxidant capacity and reduced inflammation and cell death in kidney tissues, suggesting a strong protective effect against acute nephrotoxicity and oxidative stress 15.
Lisinopril in Chronic Kidney Disease and Diabetic Nephropathy
In chronic kidney disease (CKD) models, lisinopril was found to reverse biochemical and histopathological signs of kidney damage, such as elevated urea, creatinine, and inflammatory cytokines, and to improve antioxidant enzyme levels. These effects were comparable to other renoprotective drugs, indicating that lisinopril’s benefits are partly due to its anti-inflammatory and antioxidant properties . In patients with diabetic nephropathy, lisinopril reduced urinary albumin excretion more effectively than atenolol, although both drugs slowed the decline in kidney function at similar rates. This suggests that lisinopril may be particularly effective in reducing proteinuria, a key marker of kidney damage in diabetes .
Lisinopril for Hypertensive Patients with Renal Impairment
Lisinopril has been shown to provide effective blood pressure control in patients with hypertension and impaired kidney function, without causing further decline in glomerular filtration rate (GFR). Over both short and long-term use, lisinopril maintained stable kidney function and was generally well tolerated, making it a suitable option for patients with existing renal impairment .
Lisinopril in Genetic and Experimental Models of Kidney Disease
In mouse models with genetic risk factors for kidney disease (such as APOL1 high-risk variants), lisinopril significantly reduced proteinuria and glomerulosclerosis, especially in certain genetic backgrounds. The protective effects were independent of blood pressure reduction, highlighting a direct benefit on kidney tissue. However, the degree of protection varied depending on the genetic variant, suggesting that individual responses to lisinopril may differ .
Lisinopril in Combination Therapies for Diabetic Kidney Disease
Combining lisinopril with other kidney-protective drugs, such as SGLT2 inhibitors (empagliflozin or dapagliflozin), has shown additive benefits in experimental models of diabetic kidney disease. These combinations improved urine and histological markers of kidney damage, reduced glomerular hypertrophy, and preserved GFR more effectively than either drug alone 68. This supports the use of combination therapy for enhanced kidney protection in diabetes.
Lisinopril and Radiation-Induced Kidney Injury
Lisinopril also mitigated radiation-induced kidney damage in animal studies by improving mitochondrial function and reducing oxidative stress in kidney tissues. This suggests a potential role for lisinopril in protecting the kidneys from injury caused by radiation exposure .
Lisinopril and Renalase Regulation
Lisinopril may also protect the kidneys by influencing renalase, an enzyme involved in blood pressure regulation and kidney health. In models of adriamycin-induced nephropathy, lisinopril reduced proteinuria, blood pressure, and kidney lesions, possibly by increasing renalase expression and secretion in kidney tissue .
Conclusion
Lisinopril demonstrates strong kidney-protective effects across a range of experimental and clinical settings. It reduces proteinuria, oxidative stress, and inflammation, preserves kidney function, and is effective in both acute and chronic kidney injury models. Its benefits are seen in hypertension, diabetic nephropathy, toxin-induced injury, and even radiation damage. Combination therapies with lisinopril may offer further protection, especially in diabetic kidney disease. Overall, lisinopril is a well-supported option for kidney protection, with evidence for both direct and indirect mechanisms of action 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic